Thursday January 23, 2020

Genetic harvesting firm ordered to contact brain tumour patients

Brain tumour patients must be informed of right to withdraw data from study

Killian Woods

Business reporter


Barry J Whyte

Chief Feature Writer

24th November, 2019

Genomics Medicine Ireland (GMI) has been ordered to run a publicity campaign to allow people to withdraw their samples from a project to harvest the genetic data of 9,000 Irish brain tumour patients.

GMI was founded in 2015 and secured funding from Google and a venture firm established by ex-Starbucks chief executive Howard Schultz. It was acquired by WuXi NextCODE in 2018 and, as part of the deal, the Irish government’s sovereign wealth fund put $70...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Breast screening is fallible, and with potential extra costs due to legal actions, questions about the viability of the programme are invevitable

John Crown | 4 days ago

Inquest report calls for 24-hour consultant cover after delay in treatment led to death of Wexford patient

Susan Mitchell | 1 week ago

HSE plans to implement HPV screening test ‘during Q1 this year’

Susan Mitchell | 1 week ago